Long-Term Follow-Up of (90)Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma
持续性高危B细胞淋巴瘤患者接受基于(90)Y-伊布妥单抗、氟达拉滨和全身照射的非清髓性异基因移植预处理方案的长期随访研究
期刊:Biology of Blood and Marrow Transplantation
影响因子:
doi:10.1016/j.bbmt.2018.06.033
Puronen, Camille E; Cassaday, Ryan D; Stevenson, Philip A; Sandmaier, Brenda M; Flowers, Mary E; Green, Damian J; Maloney, David G; Storb, Rainer F; Press, Oliver W; Gopal, Ajay K
